KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Change in Accured Expenses: 2010-2015

Historic Change in Accured Expenses for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to $1.2 million.

  • Biocryst Pharmaceuticals' Change in Accured Expenses rose 1.99% to $1.2 million in Q4 2015 from the same period last year, while for Dec 2015 it was $717,000, marking a year-over-year decrease of 66.84%. This contributed to the annual value of $4.2 million for FY2021, which is 38.40% down from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Change in Accured Expenses of $1.2 million as of Q4 2015, which was up 15.18% from $1.1 million recorded in Q3 2015.
  • Biocryst Pharmaceuticals' Change in Accured Expenses' 5-year high stood at $5.8 million during Q4 2012, with a 5-year trough of -$7.1 million in Q1 2013.
  • Its 3-year average for Change in Accured Expenses is $69,167, with a median of $1.1 million in 2014.
  • Per our database at Business Quant, Biocryst Pharmaceuticals' Change in Accured Expenses surged by 5,069.05% in 2014 and then slumped by 228.56% in 2015.
  • Over the past 5 years, Biocryst Pharmaceuticals' Change in Accured Expenses (Quarterly) stood at -$979,000 in 2011, then soared by 697.24% to $5.8 million in 2012, then tumbled by 50.81% to $2.9 million in 2013, then tumbled by 58.10% to $1.2 million in 2014, then climbed by 1.99% to $1.2 million in 2015.
  • Its Change in Accured Expenses stands at $1.2 million for Q4 2015, versus $1.1 million for Q3 2015 and -$2.8 million for Q2 2015.